Intel CFO Says 14A Defect Density Progress Beats Past Nodes, Customer Talks Shift to Capacity

Intel’s 22-nm Ivy Bridge process, launched in early 2012, was its first FinFET and set a yield benchmark through 2016. Later nodes faced setbacks: 10 nm missed targets, the 20A node was cancelled, and 18A suffered high defect density even after high-volume manufacturing (HVM). The upcoming 14A node—classified as a 1.4 nm-class technology—introduces second-generation GAA RibbonFET transistors, second-generation backside power delivery (PowerDirect), and High-NA EUV lithography.

Intel 14A defect density is dropping faster than the company expected — 'we have not seen this performance since 22nm,' says CFO

• August 26 2026: CFO David Zinsner spoke at the Deutsche Bank Technology Conference about 14A defect-density trends and customer engagement.

Intel 14A: Defect Density Better Than Planned

• Second half of 2027: Intel plans risk production of 14A-based products.

Intel 14A: Defect Density Better Than Planned

• 2028: Target for HVM of the 14A node.

Intel 14A defect density is dropping faster than the company expected — 'we have not seen this performance since 22nm,' says CFO

• Intel targets for 14A versus 18A include 15-20 % higher performance at equal power, 25-35 % lower energy consumption for the same performance, and up to 30 % greater chip density.

Intel 14A: Defect Density Better Than Planned

• In Q2 2026 the Intel Foundry segment generated $5.77 billion in revenue, a 31 % year-over-year increase, but posted an operating loss of $2.09 billion.

Intel Stock Falls 2.9% As 14A Progress Faces Foundry Loss

Zinsner said the defect-density curve for 14A is improving faster than Intel’s internal expectations and faster than any previous node, a pace not seen since the 22 nm era. He noted a shift from purely technical evaluation to concrete discussions about manufacturing capacity and supply commitments, with weekly meetings led by CEO Lip-Bu Tan. Intel has not disclosed any signed external 14A manufacturing contracts, but the move toward capacity-focused talks is presented as a positive signal for the foundry business.

Intel 14A: Defect Density Better Than Planned

• “When you look at the defect density, 14A is tracking better than the target curve we had for 14A,” — David Zinsner.

Intel 14A defect density is dropping faster than the company expected — 'we have not seen this performance since 22nm,' says CFO

Accelerated defect-density reduction can raise wafer yield, potentially lowering production costs and improving capacity utilization once HVM begins. The shift of external customers to capacity negotiations suggests growing confidence in Intel’s ability to supply an advanced-node foundry service—a key factor for recouping the multi-billion-dollar capital invested in 14A. RibbonFET 2, PowerDirect, and High-NA EUV also promise higher performance per watt and greater integration density than 18A.

Intel's 14A defect density improvement is best since 22nm; CFO says customers shifting from evaluating data to competing for capacity — BigGo Finance

Sources agree defect density is an early indicator, not a direct measure of final product yield. No independent yield data or third-party validation of the reported trajectory has been released, and no binding manufacturing contracts have been publicly confirmed.

Intel's 14A defect density improvement is best since 22nm; CFO says customers shifting from evaluating data to competing for capacity — BigGo Finance

Intel aims to start risk production of 14A in late 2027, followed by HVM in 2028. The 0.9 µm process-design kit release in October 2026 will enable early design work. Stakeholders will watch for the first external orders and yield data from the risk-production phase to assess whether defect-density improvements translate into profitable, high-volume manufacturing.

Intel Stock Falls 2.9% As 14A Progress Faces Foundry Loss